首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency.
【24h】

Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency.

机译:甘露糖结合凝集素相关的丝氨酸蛋白酶2缺乏症的临床渗透率低。

获取原文
获取原文并翻译 | 示例
           

摘要

To the Editor:The complement system plays a key role in innate immune responses. Complement deficiencies of early classical pathway (CP) or alternative pathway (AP) components are associated with increased susceptibility to pyogenic infections with encapsulated bacteria and to autoimmune and inflammatory disorders, particularly systemic lupus erythematosus (SLE). A third pathway, the lectin pathway (LP), is triggered by binding of mannose-binding lectin (MBL) or other lectins, such as L-ficolins and H-ficolins, to specific pathogen-associated molecular patterns on microbial surfaces. Thereafter, the MBL-associated serine protease 2 (MASP-2) cleaves complement factors C4 and C2, generating the C3 convertase, C4bC2b.
机译:致编者:补体系统在先天免疫反应中起着关键作用。早期经典途径(CP)或替代途径(AP)成分的互补缺陷与对包囊细菌的化脓性感染以及自身免疫和炎性疾病(特别是系统性红斑狼疮(SLE))的敏感性增加相关。第三种途径,即凝集素途径(LP),是由甘露糖结合凝集素(MBL)或其他凝集素(如L-ficolins和H-ficolins)与微生物表面上与病原体相关的特定分子模式结合而触发的。此后,MBL相关的丝氨酸蛋白酶2(MASP-2)裂解补体因子C4和C2,生成C3转化酶C4bC2b。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号